NCT04125927View on ClinicalTrials.gov

Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions

Cystinosis

Interventions

DRUG

Mercaptamine

Patients will be treated with 1 drop in each eye 4 times a day, at the same dose and regimen than the one indicated in adults and children from 2 years of age.

Trial Locations (6)

3000

UZ Leuven, Leuven

Unknown

Hôpital Necker-Enfants Malades, Paris

Klinik für Pädiatrische Nieren, Hanover

00146

Bambin Gesù Hospital in Palidoro, Roma

WC1N3JH

Great Ormond Street Hospital, London

M139WL

Manchester Royal Eye Hospital, Manchester

All Listed Sponsors

lead

Recordati Rare Diseases

INDUSTRY

NCT04125927 - Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) | Biotech Hunter | Biotech Hunter